Navigation Links
Reportlinker Adds Triple Analysis: Leukemia, Prostate Cancer and Apoptosis
Date:5/3/2011

g knowledge for you to consider the therapeutic target for the highest therapeutic outcome and return on investment

This report provides systems, analytical and strategic support both internally to PPP and to stakeholders across your own organization. The report will also be an important part of creating and implementing a market development plan for cancer drugs to insure that the optimal market conditions exist by the time the products are commercialized.

Key Topics Covered:

Part I: Leukemia

5.1 The Scope of this Report 29

6 Consider the Therapeutic Target Among Leukemia Drugs for the Highest Therapeutic Outcome and Return on Investment (204 Drug Targets) 33-443

7 Emerging New Products to Established Ones: Drug Target Strategies of Leukemia Drugs by their Highest Stage of Development (193 Drug Target Strategies and 313 Leukemia Drugs) 444-727

8 Compound Strategies at Work: Competitive Benchmarking of Leukemia Drugs by Compound Strategy (8 Compound Strategies) 679-728

9 Selecting Subindication for Leukemia Drugs (8 Subindications of Leukemia) 729-762

10 Pipeline and Portfolio Planning: Competitive Benchmarking of the Leukemia Drug Pipeline by Investigator (186 Companies) 763-1,129

11 Disclaimer 1130

12 Drug Index 1131

13 Company Index 1140

Figures: Includes 6 Figures

Tables: Includes 253 Tables

Total Number of Pages: 1,147

Part II: Prostate Cancer

5.1 The Scope of this Report 28

6 Consider the Therapeutic Target for the Highest Therapeutic Outcome and Return on Investment (202 Drug Targets) 32-383

7 Emerging New Products to Established Ones: Drug Target Strategies by their Highest Stage of Development in the Prostate Cancer Pipeline (187 Drug Target Strategies and 346 Drugs) 384-438

8 Compound Strategies at Work: Competitive Benchmarking of Prostate Cancer Drugs by Compound Strategy (8 Different Compound Strategies) 439-
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Reportlinker Adds Triple Analysis: Colorectal Cancer, Leukemia and Apoptosis
2. Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition
3. Reportlinker Adds Triple Analysis: Leukemia, Pancreatic Cancer and Prostate Cancer
4. Reportlinker Adds Cancer Reports Bundle
5. Reportlinker Adds Medical Imaging Technologies for Oncology Diagnostics: The Global Market
6. Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies
7. Reportlinker Adds Advanced Lung Cancer in Patient Smoker with Squamous Cell: Clinical Insights from a US Oncologists Survey
8. Reportlinker Adds Advanced Lung Cancer with EGFR Mutation Positive Adenocarcinoma
9. Reportlinker Adds Pharmaceutical Key Trends 2011 - Prescription Pharmaceutical Sales Overview
10. Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify
11. Reportlinker Adds Pharmaceutical Key Trends 2011 - Biosimilar Market Overview
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014  Decision Resources ... multiple sclerosis (MS) patients currently treated with ... have ever experienced flushing and/or gastrointestinal events ... patients are currently experiencing these side effects, ... effective medical management of such events. In ...
(Date:7/22/2014)... 2014 Research and Markets  has announced ... report to their offering. ... to diagnose, monitor, and assess medical conditions, diseases, or ... outcomes for earlier and more targeted treatment. These tests ... accurate results. This kind of diagnostics provides early detection ...
(Date:7/22/2014)... July 22, 2014  Eyeon Therapeutics has received a ... based on a charged hydrophilic polymer developed at Particles ... been shown to be safe and effective in a ... CEO states, "This first set of claims around the ... to moving this technology into the commercial phase.  We ...
Breaking Medicine Technology:Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 3Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 2Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 3Particle Sciences and Eyeon Therapeutics Receive Patent on Novel Dry Eye Technology 2
... MonoSol Rx, the developers of PharmFilm® technology and ... film products, today announced that it held a ... Food and Drug Administration (FDA) regarding the development ... a 505(b)(2) pathway.  The registration dossier of Montelukast ...
... 2011 PTC Therapeutics, Inc. (PTC) today announced the ... Medical Officer.  Dr. Spiegel served previously as Chief Medical ... of Jay Barth, M.D. to Vice President of Clinical ... Spiegel will report to Stuart W. Peltz, Ph.D., President ...
Cached Medicine Technology:MonoSol Rx Secures 505(b)(2) Regulatory Pathway for Montelukast Sodium Oral Soluble Film 2MonoSol Rx Secures 505(b)(2) Regulatory Pathway for Montelukast Sodium Oral Soluble Film 3PTC Therapeutics Appoints Robert Spiegel, M.D. as Chief Medical Officer 2PTC Therapeutics Appoints Robert Spiegel, M.D. as Chief Medical Officer 3
(Date:7/22/2014)... Plate Club you eat pretty much everything you put ... Cornell University study shows that the average adult eats 92% ... plate. "If you put it on your plate, ... of the forthcoming book, Slim by Design, Professor of Marketing ... Wansink and co-author Katherine Abowd Johnson analyzed 1179 diners and ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Legislation ... Seniors Access to Local Pharmacies Act of 2014”) ... Part D would undermine the availability of lower ... by $21 billion over the next 10 years, ... released by the Pharmaceutical Care Management Association (PCMA). ...
(Date:7/22/2014)... New Rochelle, NY -- New guidelines on cholesterol treatment ... least double the risk of dying from atherosclerotic cardiovascular ... as do women with a similar risk profile (based ... levels). The implications of this finding for when and ... an Editorial in Journal of Men,s Health , ...
(Date:7/22/2014)... July 22, 2014 The Pennsylvania ... ) in the Philadelphia Court of ... punitive damages in cases alleging the medication caused ... Liebhard LLP reports. In an Order dated July ... plaintiffs’ request to certify the matter for an ...
(Date:7/22/2014)... News) -- One of the largest studies ever conducted ... uncovered 83 new sites on chromosomes that harbor inherited ... an international team of researchers, now bring the total ... to 108. Although these schizophrenia-associated genes aren,t ... predict who will or will not develop the illness, ...
Breaking Medicine News(10 mins):Health News:PCMA: New Study Finds H.R. 4577 to Cost $21 Billion Over 10 Years 2Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 4Health News:Gene Discoveries Could Shed New Light on Schizophrenia 2
... Edward G.,Rendell today issued an executive order regarding ... closed after the law,authorizing its operation expired on ... 2003, when PHC4 was allowed to "sunset",by the ... action., The Rendell administration is committed to ...
... Illinois at Chicago is one of 11 centers in ... in the Clinical Islet Transplant Consortium funded by the ... clinical studies to test new approaches to islet transplantation ... effects for adults with difficult-to-control type 1 diabetes. , ...
... to vote soon on legislation that would cut ... WASHINGTON, July 8 Seniors across,Pennsylvania are speaking ... in legislation being considered in the U.S. Senate. ... the Medicare Advantage,program in Pennsylvania alone and severely ...
... DETROIT, July 8 The Barbara Ann Karmanos,Cancer ... with Meadowbrook C,Management, LLC, to lease space and ... Michigan. The approximately 14,000 square foot,space will allow ... in Novi,and the surrounding communities, as well as ...
... cancer research, particularly in observational epidemiology studies. The ... mitigated if researchers use more exacting standards when ... in the July 8 online issue of the ... Additionally, the impact of false-positive results could be ...
... in Iron Blood Levels Associated with Decreased Cancer Risk in ... arterial disease who participated in a randomized controlled trial in ... a reduced incidence of cancer relative to men in the ... have suggested that lower levels of iron in the blood ...
Cached Medicine News:Health News:Governor Rendell Issues Executive Order Regarding Pennsylvania Health Care Cost Containment Council 2Health News:Governor Rendell Issues Executive Order Regarding Pennsylvania Health Care Cost Containment Council 3Health News:UIC in NIH-funded islet transplantation study for type 1 diabetes 2Health News:Pennsylvania Seniors Speak Out Against Medicare Advantage Cuts 2Health News:Karmanos Cancer Center Partners With Meadowbrook to Expand Outreach and Access for Cancer Services 2Health News:Awareness of epidemiology's limitations could reduce impact of false-positive cancer results 2Health News:Also in the July 8 JNCI 2Health News:Also in the July 8 JNCI 3Health News:Also in the July 8 JNCI 4
Standard vice clamp, can be fitted instead of Quick Realease Cassette...
Knife sharpening kit...
... work, it is necessary to cool a specimen ... be fitted to most microtomes and will permit ... depending on conditions. The equipment consists of a ... stage is best suited for operation with a ...
... some sectioning work, it is necessary to cool ... Freezer can be fitted to most microtomes and ... or lower, depending on conditions. The equipment consists ... The cooling stage is best suited for operation ...
Medicine Products: